Related references
Note: Only part of the references are listed.Transcriptomic Analysis of Diffuse Intrinsic Pontine Glioma (DIPG) Identifies a Targetable ALDH-Positive Subset of Highly Tumorigenic Cancer Stem-like Cells
Rachel K. Surowiec et al.
MOLECULAR CANCER RESEARCH (2021)
Suprising phenotypic diversity of cancer-associated mutations of Gly 34 in the histone H3 tail
Brandon R. Lowe et al.
ELIFE (2021)
Pediatric hemispheric high-grade glioma: targeting the future
Christina Coleman et al.
CANCER AND METASTASIS REVIEWS (2020)
PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers
Reem Ali et al.
CANCER LETTERS (2020)
Invited Review: Emerging functions of histone H3 mutations in paediatric diffuse high-grade gliomas
L. H. Kasper et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
H3K36me3, message from chromatin to DNA damage repair
Zhongxing Sun et al.
CELL AND BIOSCIENCE (2020)
Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib
Zhaohui Wang et al.
MOLECULAR CANCER RESEARCH (2020)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
Diffuse Intrinsic Pontine Glioma Cells Are Vulnerable to Mitotic Abnormalities Associated with BMI-1 Modulation
Shiva Senthil Kumar et al.
MOLECULAR CANCER RESEARCH (2020)
H3K4me2 regulates the recovery of protein biosynthesis and homeostasis following DNA damage
Siyao Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Radio-Resistance and DNA Repair in Pediatric Diffuse Midline Gliomas
Henriette Pedersen et al.
CANCERS (2020)
Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities
Santiago Haase et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Histone methylation and the DNA damage response
Fade Gong et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2019)
A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications
Matthieu Gobin et al.
CANCER RESEARCH (2019)
Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma
Mwangala Precious Akamandisa et al.
NEURO-ONCOLOGY (2019)
Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
Hiroaki Katagi et al.
CLINICAL CANCER RESEARCH (2019)
PARP1 regulates DNA damage-induced nucleolar-nucleoplasmic shuttling of WRN and XRCC1 in a toxicant and protein-specific manner
Sebastian Veith et al.
SCIENTIFIC REPORTS (2019)
Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of melanoma patients
Petr Nazarov et al.
BMC MEDICAL GENOMICS (2019)
TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
Coralie Werbrouck et al.
CLINICAL CANCER RESEARCH (2019)
Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets
Razina Aziz-Bose et al.
CURRENT OPINION IN ONCOLOGY (2019)
Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
Fatma E. El-Khouly et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Hypoxic Environment and Paired Hierarchical 3D and 2D Models of Pediatric H3.3-Mutated Gliomas Recreate the Patient Tumor Complexity
Anne-Florence Blandin et al.
CANCERS (2019)
Constitutional mismatch repair deficiency-associated brain tumors: report from the European C4CMMRD consortium
Lea Guerrini-Rousseau et al.
NEURO-ONCOLOGY ADVANCES (2019)
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial
Alan Mackay et al.
CANCER CELL (2018)
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
DNA mismatch repair in cancer
Marina Baretti et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutS alpha interaction
Jun Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention
Reem Ali et al.
CANCER RESEARCH (2018)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
An Innovative Fluorescent Semi-quantitative Methylation-specific PCR Method for the Determination of MGMT Promoter Methylation is Reflecting Intra-tumor Heterogeneity
Aurelia Nguyen et al.
CURRENT CANCER DRUG TARGETS (2015)
Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome
Carol A. Durno et al.
EUROPEAN JOURNAL OF CANCER (2015)
Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma
Yevgen Chornenkyy et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks
Francois Aymard et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
SETD2-Dependent Histone H3K36 Trimethylation Is Required for Homologous Recombination Repair and Genome Stability
Sophia X. Pfister et al.
CELL REPORTS (2014)
Identification of Poly(ADP-Ribose) Polymerase-1 as a Cell Cycle Regulator through Modulating Sp1 Mediated Transcription in Human Hepatoma Cells
Liu Yang et al.
PLOS ONE (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
Dannis G. van Vuurden et al.
ONCOTARGET (2011)
MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature
Nathalie Gaspar et al.
CANCER RESEARCH (2010)
MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents
Bernd Kaina et al.
DNA REPAIR (2007)
Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia
E Guérin et al.
LEUKEMIA (2003)
Share Paper
